Therapeutic angiogenesis in patients with systemic sclerosis by autologous transplantation of bone-marrow-derived cells

Modern Rheumatology

Volumn 20, Issue 3, 2010, Pages 263-272

  Ishigatsubo, Yoshiaki ^a   Ihata, Atsushi ^a   Kobayashi, Hiroshi ^a   Hama, Maasa ^a   Kirino, Yohei ^a   Ueda, Atsuhisa ^a   Takeno, Mitsuhiro ^a   Shirai, Akira ^b   Ohno, Shigeru ^c  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

Angiogenesis; Autologous transplantation; Bone marrow derived cells; Intractable ulcer; Systemic sclerosis

Indexed keywords

ADULT; AGED; ANGIOGENESIS; ANGIOSCOPY; ARTICLE; AUTOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; FEMALE; HUMAN; LASER DOPPLER FLOWMETRY; MIDDLE AGED; PAIN ASSESSMENT; PATIENT SELECTION; QUESTIONNAIRE; SKIN ULCER; SYSTEMIC SCLEROSIS; TREATMENT OUTCOME;

ADULT; AGED; BONE MARROW TRANSPLANTATION; FEMALE; HUMANS; LASER-DOPPLER FLOWMETRY; MICROSCOPIC ANGIOSCOPY; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; PAIN MEASUREMENT; PATIENT SELECTION; QUESTIONNAIRES; SCLERODERMA, SYSTEMIC; SKIN ULCER; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 77956644934     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-010-0274-x     Document Type: Article

References (20)

1. Folkman J. Angiogenesis. J Biol Chem. 1992;267:10931-4.
2. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964-7. (Pubitemid 27087709)
3. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 1999;85:221-8. (Pubitemid 29377293)
4. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med. 1999;5:434-8. (Pubitemid 29180584)
5. Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, Eguchi H, et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest. 2000; 105:1527-36. (Pubitemid 30390303)
6. Noishiki Y, Tomizawa Y, Yamane Y, Matsumoto A. Autocrine angiogenic vascular prosthesis with bone marrow transplantation. Nat Med. 1996;2:90-3. (Pubitemid 26028077)
7. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A, et al. Evidence for circulating bone marrow-derived endothelial cells. Blood. 1998;92:362-7. (Pubitemid 28323695)
8. Kamihata H, Matsubara H, Nishiue T, Fujiyama S, Tsutsumi Y, Ozono R, et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation. 2001;104: 1046-52. (Pubitemid 32803883)
9. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet. 2002;360:427-35.
10. Sapadin AN, Esser AC, Fleischmajer R. Immunopathogenesis of scleroderma-evolving concepts. Mt Sinai J Med. 2001;68: 233-42.
11. Herrick AL, Clark S. Quantifying digital vascular disease in patients with primary Raynaud's phenomenon and systemic sclerosis. Ann Rheum Dis. 1998;57:70-8. (Pubitemid 28177533)
12. Taylor MH, McFadden JA, Bolster MB, Silver RM. Ulnar artery involvement in systemic sclerosis (scleroderma). J Rheumatol. 2002;29:102-6. (Pubitemid 34041865)
13. Charles C, Clements P, Furst DE. Systemic sclerosis: hypothesis-driven treatment strategies. Lancet. 2006;367:1683-91. (Pubitemid 43728250)
14. Distler O, Del Rosso A, Giacomelli R, Cipriani P, Conforti ML, Guiducci S, et al. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Arthritis Res. 2002;4:R11.
15. Choi JJ, Min DJ, Cho ML, Min SY, Kim SJ, Lee SS, et al. Elevated vascular endothelial growth factor in systemic sclerosis. J Rheumatol. 2003;30:1529-33.
16. Kuwana M, Okazaki Y, Yasuoka H, Kawakami Y, Ikeda Y. Defective vasculogenesis in systemic sclerosis. Lancet. 2004; 364:603-10. (Pubitemid 39094178)
17. Cipriani P, Guiducci S, Miniati I, Cinelli M, Urbani S, Marrelli A, et al. Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis. Arthritis Rheum. 2007;56: 1994-2004. (Pubitemid 47110398)
18. Allanore Y, Batteux F, Avouac J, Assous N, Weill B, Kahan A. Levels of circulating endothelial progenitor cells in systemic sclerosis. Clin Exp Rheumatol. 2007;25:60-6. (Pubitemid 46477487)
19. Del Papa N, Quirici N, Soligo D, Scavullo C, Cortiana M, Borsotti C, et al. Bone marrow endothelial progenitors are defective in systemic sclerosis. Arthritis Rheum. 2006;54:2605-15. (Pubitemid 44205023)
20. Miyamoto K, Nishigami K, Nagaya N, Akutsu K, Chiku M, Kamei M, et al. Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitis obliterans. Circulation. 2006;114:2679-84. (Pubitemid 44967352)